Cannabinoid enantiomer action on the cytoarchitecture

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Synthetic cannabinoids, including enantiomers of 7-hydroxy-delta 6-tetrahydrocannabinol-dimethylheptyl, are investigated for their biological effects.
• Pheochromocytoma cells (PC-12) serve as a model for studying neuronal differentiation and cellular responses to various compounds.

Purpose of the Study:

• To compare the differential effects of the negative (HU-210) and positive (HU-211) enantiomers of a synthetic cannabinoid on PC-12 cells.
• To investigate the impact of these enantiomers on cell viability, proliferation, cytoskeleton, and gene expression.

Main Methods:

• Utilized epifluorescence and confocal microscopy to examine cellular cytoarchitecture.
• Assessed cell viability and proliferation.
• Quantified tubulin and actin mRNA levels using RT-PCR or similar techniques.

Main Results:

• HU-210 significantly suppressed cell viability and proliferation in differentiating PC-12 cells compared to HU-211.
• HU-210 disrupted microtubule and microfilament distribution and induced vacuole formation, while HU-211 had minimal effects on cytoarchitecture.
• HU-210 markedly reduced tubulin and actin mRNA levels, whereas HU-211 had a negligible impact on these transcripts.

Conclusions:

• The positive enantiomer HU-211 exhibits significantly less cellular activity compared to the negative enantiomer HU-210.
• HU-210 demonstrates potent cytotoxic and disruptive effects on PC-12 cells, impacting cytoskeleton and gene expression.
• The cellular activity of delta 1-THC in differentiating cells falls between that of HU-210 and HU-211.